Entity

MannKind Corporation

biopharmaceutical company

Express your sentiment! Sign in!
Entity sentiment
1
Business
MannKind pushes for FDA approval in 2025 amid diabetes treatment controversy
MannKind Corporation Food and Drug Administration
You've reached the end